COVID-19 infection in a patient with multiple sclerosis treated with fingolimod

Volume: 7, Issue: 4, Pages: e753 - e753
Published: May 5, 2020
Abstract
In December 2019, a novel coronavirus causing an infectious respiratory disease (COVID-19) was identified, which since then has developed into a pandemic with higher rates of mortality in older individuals and those with underlying medical conditions.1 Multiple sclerosis (MS) is an immune-mediated neurologic disease which requires long-term treatment with immunotherapies that have been shown to increase the risk of infections.2 As a result,...
Paper Details
Title
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
Published Date
May 5, 2020
Volume
7
Issue
4
Pages
e753 - e753
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.